Arrayit Corporation (OTC: ARYC) announces today that the company's patented and proprietary microarray life sciences product and services portfolio is available for purchase on-line through Amazon.com, Inc., the world's largest on-line retailer. Customers can now purchase Arrayit products on a continuous worldwide basis by navigating to the Amazon.com web site and entering "Arrayit" as the search term.
Amazon, an American international electronic commerce company headquartered in Seattle, Washington, USA, reported $61B in revenue in 2012, and trades at $355 per share with a $162B market cap on NASDAQ as ticker symbol AMZN. ARYC is utilizing the massive Amazon distribution channel as an important component of the company's expansion plans, which include sales and earnings growth through enhanced worldwide sales to scientists, clinicians and consumers.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
Investor and Media Contact
John Nesbett and Jennifer Belodeau
Institutional Marketing Services (IMS)
203.972.9200
JNesbett@InstitutionalMS.com
jbelodeau@InstitutionalMS.com
